Literature DB >> 34261453

Downregulation of tumor-derived exosomal miR-34c induces cancer-associated fibroblast activation to promote cholangiocarcinoma progress.

Xinglei Qin1, Min Lu2, Gang Li3, Yajun Zhou3, Zhaoyang Liu3.   

Abstract

BACKGROUND: This study aimed to investigate the exact regulatory mechanisms of exosomal miR-34c in mediating communication between cholangiocarcinoma cells and fibroblasts.
METHODS: Exosomes were isolated from HuCCT-1 and HIBEC cells using differential ultracentrifugation and identified by transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA) method. Real-time quantitative PCR (qRT-PCR) and western blotting analyses were performed to assess the levels of pro-inflammatory factors, and fibroblast-related proteins and Wnt-linked signaling pathway proteins, respectively. Exosome-tracking was performed with confocal microscopy. The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) and Transwell assays were used to measure cell proliferation and migration, respectively. Further, the oncogenicity of cholangiocarcinoma cells was analyzed in nude mice transplanted tumor model.
RESULTS: The analysis suggested that the expression of miR-34c was decreased in exosomes from HuCCT-1 cells. Moreover, miR-34c in exosomes mediated fibroblast activation by directly targeting WNT1. Additionally, cancer-associated fibroblasts (CAFs) activated by downregulation of exosomal miR-34c promoted cholangiocarcinoma progression.
CONCLUSIONS: Thus, miR-34c in exosomes was found to be a key player in regulating intercellular communication between tumor cells and fibroblasts.
© 2021. The Author(s).

Entities:  

Keywords:  Cholangiocarcinoma; Exosomes; Fibroblasts; WNT1; miR-34c

Year:  2021        PMID: 34261453     DOI: 10.1186/s12935-020-01726-6

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  36 in total

Review 1.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

2.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

Review 3.  Targeting cancer-related inflammation in the era of immunotherapy.

Authors:  Kyohei Nakamura; Mark J Smyth
Journal:  Immunol Cell Biol       Date:  2017-01-10       Impact factor: 5.126

Review 4.  Microenvironmental regulation of therapeutic response in cancer.

Authors:  Florian Klemm; Johanna A Joyce
Journal:  Trends Cell Biol       Date:  2014-12-22       Impact factor: 20.808

Review 5.  Cancer-related inflammation.

Authors:  Juliana Candido; Thorsten Hagemann
Journal:  J Clin Immunol       Date:  2012-12-09       Impact factor: 8.317

Review 6.  Drug resistance and the solid tumor microenvironment.

Authors:  Olivier Trédan; Carlos M Galmarini; Krupa Patel; Ian F Tannock
Journal:  J Natl Cancer Inst       Date:  2007-09-25       Impact factor: 13.506

Review 7.  Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.

Authors:  Hua Fang; Yves A Declerck
Journal:  Cancer Res       Date:  2013-08-02       Impact factor: 12.701

Review 8.  Cholangiocarcinoma: Current Knowledge and New Developments.

Authors:  Boris Blechacz
Journal:  Gut Liver       Date:  2017-01-15       Impact factor: 4.519

Review 9.  Role of tumor microenvironment in tumorigenesis.

Authors:  Maonan Wang; Jingzhou Zhao; Lishen Zhang; Fang Wei; Yu Lian; Yingfeng Wu; Zhaojian Gong; Shanshan Zhang; Jianda Zhou; Ke Cao; Xiayu Li; Wei Xiong; Guiyuan Li; Zhaoyang Zeng; Can Guo
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

10.  Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment.

Authors:  Vladimir M Perelmuter; Liubov A Tashireva; Olga E Savelieva; Evgeny V Denisov; Evgeniya V Kaigorodova; Marina V Zavyalova; Nadezhda V Cherdyntseva
Journal:  Breast Cancer (Dove Med Press)       Date:  2019-07-05
View more
  4 in total

1.  Potential of extracellular vesicles and exosomes as diagnostic markers for cholangiocarcinoma.

Authors:  Linping Cao; Jiawei Hong; Jian Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

Review 2.  Exosomes in the tumor microenvironment of cholangiocarcinoma: current status and future perspectives.

Authors:  Kai Zhao; Xiangyu Li; Yuanxin Shi; Yun Lu; Peng Qiu; Zhengdong Deng; Wei Yao; Jianming Wang
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

Review 3.  Advances of cancer-associated fibroblasts in liver cancer.

Authors:  Hao Peng; Erwei Zhu; Yewei Zhang
Journal:  Biomark Res       Date:  2022-08-16

Review 4.  Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies.

Authors:  Hengsong Cao; Tian Huang; Mingrui Dai; Xiangyi Kong; Hanyuan Liu; Zhiying Zheng; Guoqiang Sun; Guangshun Sun; Dawei Rong; Zehua Jin; Weiwei Tang; Yongxiang Xia
Journal:  Int J Biol Sci       Date:  2022-08-21       Impact factor: 10.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.